Michelle Min, MD, MS, reviewed best practices for managing cutaneous lupus and discussed emerging therapies practitioners ...

Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...

Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...

Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...

Dermatology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Phase 3 ONWARD3 data demonstrate sustained skin clearance, pruritus relief, and quality of life improvements with ...

BRAVE-AA-PEDS data presented at FC26 show baricitinib maintained significant hair regrowth through 76 weeks in adolescents ...

Creams, sprays and washes that promise relief from genital herpes are easy to order online, but none of them are FDA-approved.

An active acupressure intervention offers clinical benefits for patients with rosacea when combined with pharmacotherapy.

Quadrivalent HPV vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth.

Tralokinumab for AD was associated with sustained improvements in disease severity and no new safety signals at 12 months in a real-life study.

While TB and meningitis are rare among patients receiving systemic psoriasis therapies, IL-17 inhibitors increase the risk for candidiasis.